(R)-Methyl 3-oxocyclopentanecarboxylate, 95.0%, 25g

Alofanib, 98.81%, 50mg

methyl N-benzyl-beta-alaninate, 95.0%, 25g

Gallic acid monohydrate, min. 98%, pa, ACS, 500 g, plastic packaging.

3-(4-(Hydroxymethyl)phenyl)propanoic acid, 95+%, 250mg

4-Fluoro-4-phenylpiperidine hydrochloride, 95+%, 250mg

2,5-Dimethylpyrazine>98.0%(GC)(T)100mL

4-Bromo-6-(trifluoromethoxy)quinoline, 95.0%, 100mg

(S)-1-(tert-Butoxycarbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid, 97.0%, 10g

N'-[2-(4-Chlorophenyl)-1-cyclopropylaminoethylidene]hydrazinecarboxylic acid tert-butyl, 95.0%, 500mg

(R)-2-(2-((tert-Butoxycarbonyl)amino)-2-methylpropanamido)-3-(1H-indol-3-yl)propanoic acid, 98%, 10g

1-(3-methylbutyl)-4-nitro-1H-pyrazole, 95.0%, 2g

(1H-Indol-4-yl)methanamine, 97.0%, 1g